We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MDG1 market cap is 28.49M. The company's latest EPS is EUR -0.6586 and P/E is -1.75.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 10.51M | 8M | 10.46M | 31.25M | 6.03M |
| Operating Income | -20.16M | -28.66M | -9.99M | -8.73M | -16.15M |
| Net Income | -19.96M | -28.88M | -9.98M | -8.33M | -16.18M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 109.22M | 74.75M | 59.47M | 51.68M | 31.72M |
| Total Liabilities | 27.39M | 21.6M | 14.65M | 14.65M | 10.65M |
| Total Equity | 81.82M | 53.15M | 44.82M | 37.03M | 21.07M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -16.42M | -24.79M | -10.75M | 11.98M | -15.12M |
| Investing | 24.17M | 21.12M | 4.03M | -12.01M | 2.38M |
| Financing | -469k | -826k | -1.03M | -282k | -776k |
| Market Cap | 28.49M |
| Price to Earnings Ratio | -1.75 |
| Price to Sales Ratio | 4.68 |
| Price to Cash Ratio | 3.26 |
| Price to Book Ratio | 1.34 |
| Dividend Yield | - |
| Shares Outstanding | 24.56M |
| Average Volume (1 week) | 18.2k |
| Average Volume (1 Month) | 29.53k |
| 52 Week Change | -37.30% |
| 52 Week High | 2.85 |
| 52 Week Low | 1.075 |
| Spread (Intraday) | 0.03 (2.55%) |
| Company Name | Medigene AG |
| Address |
lochhamer strasse 11 munich 82152 |
| Website | https://www.medigene.de |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
